by The global Uterine Manipulation Devices market size is expected to be worth around US$ 473.81 Mn by 2030, according to a new report by Vision Research Reports.
Uterine Manipulation Devices Market (By Application: Total Laparoscopy Hysterectomy (TLH), Laparoscopic Supracervical Hysterectomy (LSH), Laparoscopically Assisted Vaginal Hysterectomy (LAVH),Sacrocolpopexy, Other Applications; By End-use: Hospitals, Clinics, Ambulatory Surgery Centers (ASCs)) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030
Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38306
Report Highlights
the hospitals segment dominated the market with a share of 59.15%. The growth of this segment can mainly be attributed to an increase in the number of patients suffering from various gynecological conditions and a consequent rise in the number of surgical procedures. Hospitals offer superior care to patients and provide reimbursements for certain procedures, which is further contributing to the segment growth. Furthermore, hospitals are currently advancing in terms of technology. Technologically advanced devices are being used extensively in hospitals to provide better treatment. These devices are not only simplifying treatment procedures but also providing better, faster, and accurate results.
The lower risk of post-surgical complications in minimally invasive laparoscopic surgery is expected to increase the demand for ambulatory surgery centers. They offer several advantages to patients including shorter procedure time and same-day discharge as compared to hospitals. Most intra-abdominal procedures can now be performed laparoscopically at ambulatory surgery centers as these are less invasive. Surgeries at ambulatory surgery centers not only have shorter stay duration but are also more affordable than inpatient procedures, which reduces patient expenditure. Thus, owing to the abovementioned factors, the ambulatory surgery centers segment is likely to witness rapid growth during the forecast period.
North America dominated the market with a share of 45.67% in 2020 and is expected to witness considerable growth over the forecast period. This is owing to the increasing number of gynecology-related surgical procedures/hospital visits, the presence of well-established healthcare infrastructure, favorable reimbursement policies, and supportive regulatory reforms in the healthcare sector. According to CMS, healthcare spending in the U.S. increased by 5.6% and reached USD 4.8 trillion in 2019, accounting for approximately 27.7% of GDP. The national health spending is expected to grow at an annual rate of 10.4% from 2019 to 2030, to reach USD 6.2 trillion by the year 2028. The ease of access to healthcare technologies and the presence of strong distribution channels are also driving the adoption of uterine manipulation devices in the region.
Key Players
- Conkin Surgical Instruments Ltd.
- Johnson and Johnson
- CooperSurgical, Inc.
- B. Braun Medical Ltd.
- KARL STORZ GmbH & Co. KG
- CONMED Corporation
- RUDOLF Medical GmbH + Co. KG
- LiNA Medical ApS
- Richard Wolf GmbH
- Utah Medical Products, Inc.
- Purple Surgical
- Clinical Innovations, LLC
- Bissinger Medizintechnik
- The O.R. Company (Symmetry Surgical Inc.)
- LSI Solutions, Inc.
Market Segmentation
- Application Outlook
- Total Laparoscopy Hysterectomy (TLH)
- Laparoscopic Supracervical Hysterectomy (LSH)
- Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
- Sacrocolpopexy
- Other Applications
- End-use Outlook
- Hospitals
- Clinics
- Ambulatory Surgery Centers (ASCs)
- Regional Outlook
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Norway
- Sweden
- Russia
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Turkey
- Qatar
- North America
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38306
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Uterine Manipulation Devices Market, By Application
7.1. Uterine Manipulation Devices Market, by Application, 2021-2030
7.1.1. Total Laparoscopy Hysterectomy (TLH)
7.1.1.1. Market Revenue and Forecast (2016-2030)
7.1.2. Laparoscopic Supracervical Hysterectomy (LSH)
7.1.2.1. Market Revenue and Forecast (2016-2030)
7.1.3. Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
7.1.3.1. Market Revenue and Forecast (2016-2030)
7.1.4. Sacrocolpopexy
7.1.4.1. Market Revenue and Forecast (2016-2030)
7.1.5. Other Applications
7.1.5.1. Market Revenue and Forecast (2016-2030)
Chapter 8. Global Uterine Manipulation Devices Market, By End-use
8.1. Uterine Manipulation Devices Market, by End-use, 2021-2030
8.1.1. Hospitals
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Clinics
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Ambulatory Surgery Centers (ASCs)
8.1.3.1. Market Revenue and Forecast (2016-2030)
Chapter 9. Global Uterine Manipulation Devices Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Application (2016-2030)
9.1.2. Market Revenue and Forecast, by End-use (2016-2030)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Application (2016-2030)
9.1.3.2. Market Revenue and Forecast, by End-use (2016-2030)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Application (2016-2030)
9.1.4.2. Market Revenue and Forecast, by End-use (2016-2030)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Application (2016-2030)
9.2.2. Market Revenue and Forecast, by End-use (2016-2030)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Application (2016-2030)
9.2.3.2. Market Revenue and Forecast, by End-use (2016-2030)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Application (2016-2030)
9.2.4.2. Market Revenue and Forecast, by End-use (2016-2030)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Application (2016-2030)
9.2.5.2. Market Revenue and Forecast, by End-use (2016-2030)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Application (2016-2030)
9.2.6.2. Market Revenue and Forecast, by End-use (2016-2030)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Application (2016-2030)
9.3.2. Market Revenue and Forecast, by End-use (2016-2030)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Application (2016-2030)
9.3.3.2. Market Revenue and Forecast, by End-use (2016-2030)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Application (2016-2030)
9.3.4.2. Market Revenue and Forecast, by End-use (2016-2030)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Application (2016-2030)
9.3.5.2. Market Revenue and Forecast, by End-use (2016-2030)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Application (2016-2030)
9.3.6.2. Market Revenue and Forecast, by End-use (2016-2030)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Application (2016-2030)
9.4.2. Market Revenue and Forecast, by End-use (2016-2030)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Application (2016-2030)
9.4.3.2. Market Revenue and Forecast, by End-use (2016-2030)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Application (2016-2030)
9.4.4.2. Market Revenue and Forecast, by End-use (2016-2030)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Application (2016-2030)
9.4.5.2. Market Revenue and Forecast, by End-use (2016-2030)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Application (2016-2030)
9.4.6.2. Market Revenue and Forecast, by End-use (2016-2030)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Application (2016-2030)
9.5.2. Market Revenue and Forecast, by End-use (2016-2030)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Application (2016-2030)
9.5.3.2. Market Revenue and Forecast, by End-use (2016-2030)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Application (2016-2030)
9.5.4.2. Market Revenue and Forecast, by End-use (2016-2030)
Chapter 10. Company Profiles
10.1. Conkin Surgical Instruments Ltd.
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Johnson and Johnson
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. CooperSurgical, Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. B. Braun Medical Ltd.
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. KARL STORZ GmbH & Co. KG
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. CONMED Corporation
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. RUDOLF Medical GmbH + Co. KG
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. LiNA Medical ApS
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Richard Wolf GmbH
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Utah Medical Products, Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Purple Surgical
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
10.12. Clinical Innovations, LLC
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
10.13. Bissinger Medizintechnik
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives
10.14. The O.R. Company (Symmetry Surgical Inc.)
10.14.1. Company Overview
10.14.2. Product Offerings
10.14.3. Financial Performance
10.14.4. Recent Initiatives
10.15. LSI Solutions, Inc.
10.15.1. Company Overview
10.15.2. Product Offerings
10.15.3. Financial Performance
10.15.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
Glossary of Terms
Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38306
About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.
Contact Us:
call: +1 9197 992 333
Vision Research Report
Any Assistance, Email – sales@visionresearchreports.com
